Status:

RECRUITING

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

Lead Sponsor:

University of Alabama at Birmingham

Collaborating Sponsors:

Varian, a Siemens Healthineers Company

Conditions:

Renal Cell Carcinoma (RCC)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Multi-center, single arm, prospective trial to estimate safety, feasibility, technical outcomes, and clinical outcomes of percutaneous cryoablation with neo-adjuvant trans-arterial embolization of the...

Eligibility Criteria

Inclusion

  • Aged ≥18 years
  • Solid renal mass consistent with RCC on either ultrasound, MRI, or CT
  • Longest tumor diameter measures 4.1-7cm
  • Tumor stage T1bN0M0 without vascular invasion, adenopathy, or distant metastatic disease
  • For females of reproductive potential: use of highly effective contraception for at least 1 month prior to enrollment and agreement to use such a method during study participation
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study

Exclusion

  • Pregnancy
  • Severe renal insufficiency with an Estimated Glomerular Filtration Rate (eGFR) \<30
  • Renal cell carcinoma as part of a syndrome
  • Horseshoe kidney
  • Patient unable to undergo renal mass protocol CT or MRI
  • Severe allergy to iodinated contrast not mitigated by steroid and diphenhydramine prophylaxis
  • Uncorrectable coagulopathy, including a platelet count of \<30,000/μL and/or an international normalized ratio (INR) \>2.5 that does not respond to platelet transfusion or prothrombin complex concentrate infusion, respectively
  • Performance status precludes enrollment as determined by the investigators

Key Trial Info

Start Date :

January 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT05410509

Start Date

January 3 2024

End Date

December 31 2027

Last Update

December 29 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

2

Stanford Cancer Institute

Stanford, California, United States, 94305

3

Mayo Clinic

Rochester, Minnesota, United States, 55905

4

Thomas Jefferson Health

Philadelphia, Pennsylvania, United States, 19107

"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)" | DecenTrialz